Search Results - "Fehmann, H C"
-
1
Plasma resistin levels in patients with type 1 and type 2 diabetes mellitus and in healthy controls
Published in Hormone and metabolic research (01-11-2002)“…Resistin is a recently discovered hormone that is exclusively expressed in adipose tissue. Its expression in rodents was reported to be elevated or suppressed…”
Get more information
Journal Article -
2
Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin-secreting beta-cells
Published in The Journal of biological chemistry (15-09-1993)“…Exendin-4 purified from Heloderma suspectum venom shows structural relationship to the important incretin hormone glucagon-like peptide 1-(7-36)- amide…”
Get full text
Journal Article -
3
Insulinotropic hormone glucagon-like peptide-I(7-37) stimulation of proinsulin gene expression and proinsulin biosynthesis in insulinoma beta TC-1 cells
Published in Endocrinology (Philadelphia) (01-01-1992)“…Glucagon-like peptide-I(7-37) [GLP-I(7-37)] is an intestinal peptide hormone that is released in response to oral nutrients and that potently augments…”
Get more information
Journal Article -
4
Glucagon-like peptide-1 and glucose-dependent insulin-releasing polypeptide plasma levels in response to nutrients
Published in Digestion (1995)“…The nutrient-dependent glucagon-like peptide-1 (7-36) amide (GLP-1) release was studied in comparison to the glucose-dependent insulin-releasing polypeptide…”
Get more information
Journal Article -
5
mRNA expression patterns of insulin-like growth factor system components in human neuroendocrine tumours
Published in European journal of clinical investigation (01-08-2000)“…Background Insulin‐like growth factors (IGF) and their corresponding receptors and binding proteins are important in carcinogenesis for several tumours, but…”
Get full text
Journal Article -
6
Reduction of the incretin effect in rats by the glucagon-like peptide 1 receptor antagonist exendin (9-39) amide
Published in Diabetes (New York, N.Y.) (01-01-1995)“…Reduction of the incretin effect in rats by the glucagon-like peptide 1 receptor antagonist exendin (9-39) amide. F Kolligs , H C Fehmann , R Göke and B Göke…”
Get full text
Journal Article -
7
Growth factor receptor expression in human gastroenteropancreatic neuroendocrine tumours
Published in European journal of clinical investigation (01-12-1998)“…Background Human gastroenteropancreatic neuroendocrine tumours are functionally and biologically heterogeneous, but their exact growth factor receptor…”
Get full text
Journal Article -
8
A new mutation in the hepatocyte nuclear factor-1-alpha gene (P224S) in a newly discovered German family with maturity-onset diabetes of the young 3 (MODY 3). Family members carry additionally the homozygous I27L amino acid polymorphism in the HNF1 alpha gene
Published in Experimental and clinical endocrinology & diabetes (01-02-2004)“…Mutations in the hepatocyte nuclear factor-1-alpha gene cause maturity onset diabetes of the young 3 (MODY 3). Here we describe a new family affected by this…”
Get more information
Journal Article -
9
Glucagon-like peptide-1(7-36) amide is a new incretin/enterogastrone candidate
Published in European journal of clinical investigation (01-04-1991)Get more information
Journal Article -
10
Cell and molecular biology of the incretin hormones glucagon-like peptide-I and glucose-dependent insulin releasing polypeptide
Published in Endocrine reviews (01-06-1995)Get more information
Journal Article -
11
Leptin inhibition of insulin secretion from isolated human islets
Published in Acta diabetologica (01-12-1997)“…Leptin is a hormone produced and secreted from the adipose tissue. Its physiological actions include the regulation of satiety, food intake and energy balance…”
Get full text
Journal Article -
12
Synergistic stimulatory effect of glucagon-like peptide-1 (7–36) amide and glucose-dependent insulin-releasing polypeptide on the endocrine rat pancreas
Published in FEBS letters (31-07-1989)“…The interaction of glucagon-like peptide-1 (7–36)amide (GLP-1) and glucose-dependent insulin-releasing polypeptide (GIP) on insulin release from the perfused…”
Get full text
Journal Article -
13
Interaction of GLP-I and leptin at rat pancreatic B-cells: effects on insulin secretion and signal transduction
Published in Hormone and metabolic research (01-11-1997)“…The incretin effect is reduced in NIDDM, although a corresponding attenuation of incretin hormone secretion does not occur. We characterized the direct…”
Get more information
Journal Article -
14
Stable expression of the rat GLP-I receptor in CHO cells: activation and binding characteristics utilizing GLP-I(7-36)-amide, oxyntomodulin, exendin-4, and exendin(9-39)
Published in Peptides (New York, N.Y. : 1980) (1994)“…Glucagon-like peptide-I (GLP-I) is a potent insulinotropic peptide that mediates its actions at pancreatic B-cells via specific receptors. In the present study…”
Get more information
Journal Article -
15
Molecular cloning, functional expression, and signal transduction of the GIP-receptor cloned from a human insulinoma
Published in FEBS letters (02-10-1995)“…Glucose-dependent insulinotropic polypeptide (GIP) plays an important role in the regulation of postprandial insulin secretion and proinsulin gene expression…”
Get full text
Journal Article -
16
Cosecretion of amylin and insulin from isolated rat pancreas
Published in FEBS letters (26-03-1990)“…Amylin, a 37 amino acid C-terminal amidated peptide is an integral part of secretory granules of pancreatic β-cells. Utilizing a specific radioimmunoassay…”
Get full text
Journal Article -
17
Treatment of endocrine gastroenteropancreatic tumors with somatostatin analogues
Published in Recent results in cancer research (2000)“…Somatostatin is a hormone that regulates the function of several exocrine and endocrine glands. The peptide mediates its actions via five different receptors…”
Get more information
Journal Article -
18
No apparent benefit of liquid formula diet in NIDDM
Published in Experimental and clinical endocrinology & diabetes (01-01-1997)“…We have studied the impact of liquid diets formulated for complete or supplemental enteral nutrition of type II, non insulin-dependent (NIDDM) diabetics on…”
Get more information
Journal Article -
19
Functional characterization of somatostatin receptors expressed on hamster glucagonoma cells
Published in The American journal of physiology (01-01-1995)“…We characterized somatostatin receptors expressed in hamster glucagonoma INR1G9 cells and the effects of somatostatin on glucagon secretion, proglucagon gene…”
Get full text
Journal Article -
20
Leptin: A Potent Inhibitor of Insulin Secretion
Published in Peptides (New York, N.Y. : 1980) (1997)“…Fehmann, H.-C., C. Peiser, H.-P. Bode, M. Stamm, P. Staats, C. Hedetoft, R. E. Lang and B. GÖKe. Leptin: A potent inhibitor of insulin secretion. Peptides…”
Get full text
Journal Article